These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 16837817)
21. Renoprotective effects of asialoerythropoietin in diabetic mice against ischaemia-reperfusion-induced acute kidney injury. Nakazawa J; Isshiki K; Sugimoto T; Araki S; Kume S; Yokomaku Y; Chin-Kanasaki M; Sakaguchi M; Koya D; Haneda M; Kashiwagi A; Uzu T Nephrology (Carlton); 2010 Feb; 15(1):93-101. PubMed ID: 20377776 [TBL] [Abstract][Full Text] [Related]
22. Carbamylated Erythropoietin Outperforms Erythropoietin in the Treatment of AKI-on-CKD and Other AKI Models. Tögel FE; Ahlstrom JD; Yang Y; Hu Z; Zhang P; Westenfelder C J Am Soc Nephrol; 2016 Nov; 27(11):3394-3404. PubMed ID: 26984884 [TBL] [Abstract][Full Text] [Related]
23. Antiapoptotic properties of erythropoiesis-stimulating proteins in models of cisplatin-induced acute kidney injury. Salahudeen AK; Haider N; Jenkins J; Joshi M; Patel H; Huang H; Yang M; Zhe H Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1354-65. PubMed ID: 18385271 [TBL] [Abstract][Full Text] [Related]
24. Erythropoietin enhances recovery after cisplatin-induced acute renal failure in the rat. Bagnis C; Beaufils H; Jacquiaud C; Adabra Y; Jouanneau C; Le Nahour G; Jaudon MC; Bourbouze R; Jacobs C; Deray G Nephrol Dial Transplant; 2001 May; 16(5):932-8. PubMed ID: 11328897 [TBL] [Abstract][Full Text] [Related]
25. Erythropoietin enhances recovery from cisplatin-induced acute renal failure. Vaziri ND; Zhou XJ; Liao SY Am J Physiol; 1994 Mar; 266(3 Pt 2):F360-6. PubMed ID: 8160783 [TBL] [Abstract][Full Text] [Related]
26. Novel renoprotective actions of erythropoietin: new uses for an old hormone. Johnson DW; Forman C; Vesey DA Nephrology (Carlton); 2006 Aug; 11(4):306-12. PubMed ID: 16889570 [TBL] [Abstract][Full Text] [Related]
27. Renoprotective effect of erythropoietin against ischaemia-reperfusion injury in a non-human primate model. Ishii Y; Sawada T; Murakami T; Sakuraoka Y; Shiraki T; Shimizu A; Kubota K; Fuchinoue S; Teraoka S Nephrol Dial Transplant; 2011 Apr; 26(4):1157-62. PubMed ID: 20935018 [TBL] [Abstract][Full Text] [Related]
28. Discovering erythropoietin's extra-hematopoietic functions: biology and clinical promise. Brines M; Cerami A Kidney Int; 2006 Jul; 70(2):246-50. PubMed ID: 16738535 [TBL] [Abstract][Full Text] [Related]
29. Protective effect of erythropoietin on renal injury induced by acute exhaustive exercise in the rat. Lin X; Qu S; Hu M; Jiang C Int J Sports Med; 2010 Dec; 31(12):847-53. PubMed ID: 21072740 [TBL] [Abstract][Full Text] [Related]
30. Renoprotection and Mechanisms of Erythropoietin and Its Derivatives Helix B Surface Peptide in Kidney Injuries. Zhang Y; Chen W; Wu Y; Yang B Curr Protein Pept Sci; 2017; 18(12):1183-1190. PubMed ID: 27634442 [TBL] [Abstract][Full Text] [Related]
32. Systemic and renal haemodynamic changes in renal schemia/reperfusion injury: impact of erythropoietin. Hussein AA; Barakat N; Awadalla A; Shokeir AA Can J Physiol Pharmacol; 2012 Nov; 90(11):1535-43. PubMed ID: 23181281 [TBL] [Abstract][Full Text] [Related]
33. Recombinant human erythropoietin attenuates renal tubulointerstitial injury in murine adriamycin-induced nephropathy. Nakazawa Y; Nishino T; Obata Y; Nakazawa M; Furusu A; Abe K; Miyazaki M; Koji T; Kohno S J Nephrol; 2013; 26(3):527-33. PubMed ID: 22684648 [TBL] [Abstract][Full Text] [Related]
34. Erythropoietin expands a stromal cell population that can mediate renoprotection. Bi B; Guo J; Marlier A; Lin SR; Cantley LG Am J Physiol Renal Physiol; 2008 Oct; 295(4):F1017-22. PubMed ID: 18653480 [TBL] [Abstract][Full Text] [Related]
35. Role of erythropoietin in prevention of amikacin-induced nephropathy. Kaynar K; Aliyazioglu R; Ersoz S; Ulusoy S; Al S; Ozkan G; Cansiz M J Nephrol; 2012; 25(5):744-9. PubMed ID: 22322815 [TBL] [Abstract][Full Text] [Related]
36. Curcumin attenuates renal ischemia and reperfusion injury-induced restrictive respiratory insufficiency. Yeh JH; Yang YC; Wang JC; Wang D; Wang JJ Transplant Proc; 2013; 45(10):3542-5. PubMed ID: 24314954 [TBL] [Abstract][Full Text] [Related]
37. Unexpected renal actions of erythropoietin. Westenfelder C Exp Nephrol; 2002; 10(5-6):294-8. PubMed ID: 12381912 [TBL] [Abstract][Full Text] [Related]
38. The protective effect of prolyl-hydroxylase inhibition against renal ischaemia requires application prior to ischaemia but is superior to EPO treatment. Wang Z; Schley G; Türkoglu G; Burzlaff N; Amann KU; Willam C; Eckardt KU; Bernhardt WM Nephrol Dial Transplant; 2012 Mar; 27(3):929-36. PubMed ID: 21742784 [TBL] [Abstract][Full Text] [Related]
39. Erythropoietin improves left ventricular function and coronary flow in an experimental model of ischemia-reperfusion injury. van der Meer P; Lipsic E; Henning RH; de Boer RA; Suurmeijer AJ; van Veldhuisen DJ; van Gilst WH Eur J Heart Fail; 2004 Dec; 6(7):853-9. PubMed ID: 15556046 [TBL] [Abstract][Full Text] [Related]
40. Experimental models of acute renal failure and erythropoietin: what evidence of a direct effect? Sturiale A; Campo S; Crascì E; Aloisi C; Buemi M Ren Fail; 2007; 29(3):379-86. PubMed ID: 17497457 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]